Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus (Q24242688)

3

0 references

author name string

Janine Hartweg

1

0 references

Rafael Perera

2

0 references

Andrew HAWN Neil

5

0 references

Andrew J Farmer

Cochrane Database of Systematic Reviews

6

0 references

publication date

23 January 2008

0 references

published in

0 references

cites work

A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effects of fish oil supplements in NIDDM subjects. Controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of fish oil concentrate on lipoprotein composition in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Essential fatty acid metabolism in south Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Long-term effects of n-3 fatty acids on serum lipids and glycaemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish oil and glycemic control in diabetes. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Biological Effects of ω-3 Fatty Acids in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish consumption and cardiovascular disease in the physicians' health study: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish oils and their possible role in the treatment of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of glyburide andω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Lack of benefit of dietary advice to men with angina: results of a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish oil in people with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Fish oil supplementation in type 2 diabetes: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Diabetes mellitus in Eskimos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Impact of covert duplicate publication on meta-analysis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

Primary nitrate tolerance in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effect of eicosapentaenoic acid and docosahexaenoic acid on diabetic osteopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Experience with fish oil treatment with special emphasis on diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

The triglyceride lowering effect of fish oils is affected by fish consumption

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effect of high fiber intake in fish oil-treated patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Importance of n-3 fatty acids in health and disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

The composition of food consumed by Greenland Eskimos.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Is it time for a clinical trial of dietary fish oil supplementation in individuals with NIDDM?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Fish Oil in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

Comparison of percent total GHb with percent HbA1c in people with and without known diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003205.PUB2

7 January 2021

10.1002/14651858.CD003205.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2219767

2219767

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference